SCHEMBL31347166

SCHEMBL31347166

CNc1ncc(Cl)c(C)c1[N+](=O)[O-]

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 5/20 0.40
KMT2A Q03164 5/20 0.40
MAPT P10636 5/20 0.40
RAB9A P51151 3/20 0.40
SMN1; SMN2 Q16637 3/20 0.40
TDP1 Q9NUW8 1/20 0.40
POLB P06746 5/20 0.40
ALDH1A1 P00352 5/20 0.40
LMNA P02545 3/20 0.40
NPC1 O15118 2/20 0.40
MAPK1 P28482 2/20 0.40
HTT P42858 2/20 0.40
OPRD1 P41143 1/20 0.40
OPRK1 P41145 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
TLR9 Q9NR96 1/20 0.40
GPR55 Q9Y2T6 1/20 0.40
HPGD P15428 1/20 0.40
CASP3 P42574 1/20 0.40
RECQL P46063 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16831824 0.80 MAPT (0.39) MEN1KMT2AMAPTRAB9ASMN1; SMN2
SCHEMBL31347217 0.79 GRIN2D (0.40) MEN1KMT2AMAPTRAB9ASMN1; SMN2
SCHEMBL17767940 0.79 GRIN2D (0.41) MEN1KMT2AMAPTRAB9ASMN1; SMN2
SCHEMBL31539799 0.79 GRIN2D (0.41) MEN1KMT2AMAPTRAB9ASMN1; SMN2
SCHEMBL27942973 0.79 GRIN2D (0.41) MEN1KMT2AMAPTRAB9ASMN1; SMN2
SCHEMBL31347124 0.78 CDK2 (0.54) MEN1KMT2AMAPTRAB9ASMN1; SMN2
SCHEMBL8873854 0.77 L3MBTL1 (0.45) MEN1KMT2AMAPTRAB9ASMN1; SMN2
SCHEMBL8872534 0.77 NAMPT (0.43) MEN1KMT2AMAPTRAB9ASMN1; SMN2
SCHEMBL31347185 0.77 CDK2 (0.41) MEN1KMT2AMAPTRAB9ASMN1; SMN2
SCHEMBL8873582 0.76 POLB (0.45) MEN1KMT2AMAPTSMN1; SMN2POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119585252-A Bicyclic heteroaryl containing compounds as IKZF2 degrading agents 翁科皮亚治疗公司和SK生命科学实验室 2025-03-07 CN disclosed